EP2080502A1 - Blister pack assembly - Google Patents
Blister pack assembly Download PDFInfo
- Publication number
- EP2080502A1 EP2080502A1 EP08100536A EP08100536A EP2080502A1 EP 2080502 A1 EP2080502 A1 EP 2080502A1 EP 08100536 A EP08100536 A EP 08100536A EP 08100536 A EP08100536 A EP 08100536A EP 2080502 A1 EP2080502 A1 EP 2080502A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- conductor
- blister pack
- carrier
- assembly according
- pack assembly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/30—Compliance analysis for taking medication
Definitions
- the present invention relates to blister pack assemblies with a blister pack having cavities for holding one drug dose each - such as in the form of a tablet, a pill or a dragee - and a closure foil, each dose of medicament being pushable out by depressing the associated cavity for removal through the closure foil, in particular blister pack arrangements which additionally have a conductor carrier which has a conductor track and is aligned relative to the cavities of the blister pack such that the conductor path can be pressed out by at least one surface defined by vertical projection of one of the cavities onto the conductor carrier, through which the medicament dose of this cavity can be pushed out is, runs, so that the trace is interrupted by pushing out this drug dose through this area.
- a completely separate interconnect loop can be provided for each cavity; or via each surface defined by vertical projection of one of the cavities on the conductor carrier, a branch of a parallel connection opens in two connections, and the number of withdrawn drug cans can be determined from the total resistance of the parallel connection whose reciprocal equals the sum of the reciprocals of the individual resistances of all intact branches is.
- the conductor carrier which consists of a flat material such as a plastic film or a multilayer film composite.
- the conductor carrier can in turn be glued to the sealing film of the blister pack.
- a self-adhesive design of the conductor carrier is customary, which is presented on a sheet-like release material and then, usually mechanically, is applied to the sealing film of the blister pack.
- a Blisterpackungsanordung of the type mentioned is from the German patent application DE 10 2004 060 213 A1 known.
- Blisterpackungsanordung defined by vertical projection of one of the cavities on the conductor carrier surface is in each case surrounded annularly by punching lines.
- the punched lines are interrupted by two formed from the flat material of the conductor carrier narrow web portions over which the conductor tracks out become.
- this object is achieved by avoiding the tearing of a web part on the circumference of the surface defined by vertical projection of one of the cavities onto the conductor carrier.
- the solution of the problem with a blister pack assembly according to claim 1 is implemented.
- the rupture of a web portion on the circumference of the surface defined by vertical projection of one of the cavities on the conductor carrier is avoided in that the web part to be cut is laid in the area defined by vertical projection of the cavity on the conductor carrier.
- Compared to the conventional design of a web portion at the edge of the plane defined by vertical projection of the cavity on the conductor carrier surface results in more favorable force introduction conditions, which tear the web part easier.
- the solution of the underlying object is implemented with a blister pack arrangement according to claim 19.
- the tearing of a web portion on the circumference of the defined by vertical projection of the cavities on the conductor carrier surface is avoided here, that is to interrupt the web no web part to break, but the conductor crosses a punching line facilitating the drug, without that at the intersection the punching line would be interrupted by a web part. So no web part has to be cut through at all.
- Punching lines can basically be provided both in the form of simple punched lines, as well as in the form of gap-like recesses.
- any variant of the invention described or indicated in the context of the present application may be particularly advantageous, depending on the economic and technical conditions in the individual case.
- individual features of the described embodiments are interchangeable or can be combined with one another as well as with measures known per se from the prior art.
- Fig. 1 the conductor carrier of a blister pack assembly according to the invention is shown in plan view.
- stamping image of the Medication removal facilitating punching lines 3 summarized in a representation.
- gap-like recesses can also be provided in partial areas. At the edge numbers are given from 1.1 to 1.10 for easier reference to the individual variants.
- a common punching pattern will usually be selected for each drug dose to be withdrawn.
- a desired conductor track guidance can allow the person skilled in the art to also access individually modified stamping images, for example for cavities 7 arranged at the corners of the blister pack.
- the conductor carrier is made of a flat material 4, which is for example a plastic film (PET, PE, PP, PVC, PA ...), a film composite or paper can act.
- the conductor tracks 1 are printed on the flat material 4.
- Each cavity 7 is assigned its own conductor loop. Whether this is consistent, about the in Fig. 1 not detailed executed connections are queried at the edge of the conductor carrier shown below. For each cavity 7, a separate connection is provided so that it can be detected from which cavity 7 the drug dose contained therein was taken.
- the printed conductors 1 and their connections can be carried out essentially as known from the prior art.
- the conductor 1 is guided via a centrally arranged in the plane defined by vertical projection of the associated cavity 7 on the conductor carrier surface web portion 2.
- the web part 2 is formed from the flat material 4 and defined by punched lines 3. Basically, this is already the narrow interruption of a punching line (as in Fig. 4 , Lower row shown) as a web part 2; in the embodiments of Fig. 1
- the web part 2 is extended in each case by Stanzlinienfort accounts, which makes the web part 2 easier to tear.
- the web part 2 may be further weakened by punching
- the branching of the punching lines 3 also facilitates the tearing open of the flat material 4 in the region of the associated cavity 7 as a whole, when the tablet, pill or dragee arranged in the cavity 7 is pushed out of the cavity 7 by pressure.
- the introduction of force is particularly favored by the fact that the web part 2 interrupts a punching line 3 which divides the surface defined by vertical projection of the associated cavity 7 on the strip carrier approximately into two halves (upper and lower in the illustration).
- the punched lines 3 can lie completely within the area defined by vertical projection of the associated cavity 7 on the strip conductor carrier (variants 1.1 to 1.9), and also extend beyond them (variant 1.10).
- FIGS. 2a-d and 3 Embodiments shown have punched lines 3, which each surrounded by vertical projection of the associated cavity 7 on the conductor carrier surface annularly.
- the punching lines 3 are not interrupted by web parts 2, but overprinted directly with the conductors 1.
- two foil layers 4a, 4b are provided with mutually offset punched lines 3a, 3b.
- the in Fig. 2b and 2c illustrated, arranged above the Blisterkavtician 7 bottom film section 12 also missing.
- the film layers 4a, 4b are glued together by means of an adhesive layer 9a.
- the adhesive force of the adhesive layer 3b can be reduced or locally canceled.
- this is possible by treating the adhesive with a so-called adhesive killer, overprinting the adhesive with a layer 10 or local printing of a film layer 4a, 4b with a non-stick coating, for example silicone paint.
- the force with which the surface defined by vertical projection of the associated cavity 7 on the conductor carrier adheres to the remaining surface of the conductor carrier can be adjusted by a suitable choice of the distance between the offset punched lines 3a, 3b.
- connection between the layers 4a and 4b may be provided, for example by means of a sealing layer, a bonding agent, welds, etc.
- the conductor carrier can be glued by means of a further adhesive layer 9b on the sealing film 11 of the blister pack.
- the cavities 7 of the blister pack are formed from a deep-drawn film 6.
- the conductor 1 can, as in Fig. 2c-d shown, printed on top of the conductor carrier, but also on its underside, as in Fig. 2a shown, or between the film layers 4a, 4b, as in Fig. 2b shown.
- the interconnects can also be connected via fewer connections than corresponds to the number of monitored drug cavities 7.
- only four corresponding contact pads 8 are provided.
- the number of withdrawn drug doses can be determined for each of the two parallel circuits from the total resistance of the parallel circuit whose reciprocal is equal to the sum of the reciprocal values of the individual resistances of all intact conductor paths branches.
- Fig. 4 again shows two embodiments in a representation which analog Fig. 3 is constructed.
- the guidance of the conductor 1 via web portions 2 is provided.
- the web parts 2 are not extended by punching line extensions, which simplifies the stamping image.
- Particularly favorable for the introduction of force is the arrangement of the punching lines 3 such that they approximately halve the areas defined by vertical projection of the associated cavities 7 on the conductor carrier.
- the punching line 3 interrupting web parts 2 are provided.
- the conductor 1 crosses the punching line directly.
- the shape of the punch lines 3 which preclude spontaneous "unfolding"
- a donation overlap as in FIG Fig. 2d shown, not required here. Rather, a version with only one film layer is possible.
- Fig. 5 shows a further embodiment similar Fig. 3 ,
- the stamped lines 3 here do not completely surround the surfaces defined by vertical projection of the associated cavities 7 on the strip conductor carrier, but form a kind of "doors".
- On one side of the formed from the punching line 3 "door gap" is overprinted with the conductor track.
- a similar Fig. 2d designed donation overlap be provided.
- the film layer 4, 4a, 4b on which the printed conductor 1 is printed is printed as thin as possible, to use an elastic printed conductor material and / or to underlay the printed conductor with a lacquer or a printable composition.
Abstract
Description
Die vorliegende Erfindung betrifft Blisterpackungsanordnungen mit einer Blisterpackung, welche Kavitäten zur Aufnahme je einer Medikamentendosis - etwa in Form einer Tablette, einer Pille oder eines Dragees - und eine Verschlussfolie aufweist, wobei jede Medikamentendosis durch Eindrücken der zugehörigen Kavität zur Entnahme durch die Verschlussfolie herausdrückbar ist, insbesondere Blisterpackungsanordnungen welche zudem einen Leiterbahnträger aufweisen, welcher eine Leiterbahn aufweist und relativ zu den Kavitäten der Blisterpackung so ausgerichtet ist, dass die Leiterbahn über mindestens eine durch senkrechte Projektion einer der Kavitäten auf den Leiterbahnträger definierte Fläche, durch welche die Medikamentendosis dieser Kavität zur Entnahme herausdrückbar ist, verläuft, so dass die Leiterbahn durch Herausdrücken dieser Medikamentendosis durch diese Fläche unterbrechbar ist.The present invention relates to blister pack assemblies with a blister pack having cavities for holding one drug dose each - such as in the form of a tablet, a pill or a dragee - and a closure foil, each dose of medicament being pushable out by depressing the associated cavity for removal through the closure foil, in particular blister pack arrangements which additionally have a conductor carrier which has a conductor track and is aligned relative to the cavities of the blister pack such that the conductor path can be pressed out by at least one surface defined by vertical projection of one of the cavities onto the conductor carrier, through which the medicament dose of this cavity can be pushed out is, runs, so that the trace is interrupted by pushing out this drug dose through this area.
Mit dem Prinzip, eine Leiterbahn beim Herausdrücken einer Medikamentendosis aus einer Blisterpackung zu unterbrechen, läßt sich auf elektronischem Wege überwachen, ob ein Patient das Medikament zu den verordneten Zeiten in den verordneten Dosen einnimmt (Patient Compliance). Hierzu ist die Leiterbahn mit einem geeigneten Auswertungsschaltkreis zu verbinden. Üblicherweise sind mehrere Leiterbahnen vorgesehen, um die Entnahme jeder in der Blisterpackung enthaltenen Einzeldosis auch separat detektieren zu können. Grundsätzlich besteht eine Vielzahl an möglichen Schaltungsvarianten. Beispielsweise kann für jede Kavität eine völlig separate Leiterbahnschleife vorgesehen sein; oder aber über jede durch senkrechte Projektion einer der Kavitäten auf den Leiterbahnträger definierte Fläche ist ein Zweig einer in zwei Anschlüsse mündenden Parallelschaltung gelegt, und die Zahl der entnommenen Medikamentendosen lässt sich aus dem Gesamtwiderstand der Parallelschaltung bestimmen, dessen Kehrwert gleich der Summe der Kehrwerte der Einzelwiderstände aller intakten Zweige ist.With the principle of interrupting a trace when pushing out a drug dose from a blister pack, it is possible to monitor electronically whether a patient is taking the drug at the prescribed times in the prescribed doses (Patient Compliance). For this purpose, the conductor must be connected to a suitable evaluation circuit. Usually, a plurality of interconnects are provided in order to be able to separately detect the removal of each individual dose contained in the blister pack. Basically, there are a large number of possible circuit variants. For example, a completely separate interconnect loop can be provided for each cavity; or via each surface defined by vertical projection of one of the cavities on the conductor carrier, a branch of a parallel connection opens in two connections, and the number of withdrawn drug cans can be determined from the total resistance of the parallel connection whose reciprocal equals the sum of the reciprocals of the individual resistances of all intact branches is.
Meist sind die Leiterbahnen auf den Leiterbahnträger aufgedruckt, welcher aus einem Flachmaterial wie etwa einer Kunststofffolie oder auch einem mehrlagigen Folienverbund besteht. Der Leiterbahnträger kann wiederum auf die Verschlussfolie der Blisterpackung aufgeklebt sein. Hierzu ist eine selbstklebende Ausführung des Leiterbahnträgers üblich, welcher auf einem bahnförmigen Abziehmaterial vorgelegt und dann, in der Regel maschinell, auf die Verschlussfolie der Blisterpackung aufgespendet wird.Most of the printed conductors are printed on the conductor carrier, which consists of a flat material such as a plastic film or a multilayer film composite. The conductor carrier can in turn be glued to the sealing film of the blister pack. For this purpose, a self-adhesive design of the conductor carrier is customary, which is presented on a sheet-like release material and then, usually mechanically, is applied to the sealing film of the blister pack.
Eine Blisterpackungsanordung der eingangs genannten Art ist aus der deutschen Offenlegungsschrift
Zum Entnehmen einer Medikamentendosis ist so nicht nur die Verschlussfolie der Blisterpackung durch Herausdrücken der Medikamentendosis zu durchtrennen sondern zusätzlich auch zumindest eines der im Leiterbahnträger vorgesehenen Stegteile, über welche die Leiterbahn verläuft. Dies erschwert die Medikamentenentnahme und kann sie bei alten und geschwächten Patienten unter Umständen gar verhindern.To remove a dose of medication so not only the sealing film of the blister pack by pushing out the drug dose to cut through but also at least one of the provided in the conductor carrier web portions over which the conductor runs. This complicates the withdrawal of medication and may even prevent it in old and weakened patients.
Vor diesem Hintergrund ist es Aufgabe der vorliegenden Erfindung, eine Blisterpackungsanordnung der eingangs genannten Art zu schaffen, welche die Medikamentenentnahme gegenüber dem Stand der Technik erleichtert, d.h. den zum Entnehmen einer Medikamentendosis erforderlichen Kraftaufwand reduziert.Against this background, it is an object of the present invention to provide a blister pack assembly of the type mentioned, which facilitates the withdrawal of medicaments compared to the prior art, i. reduced the effort required to remove a dose of medication.
Erfindungsgemäß wird diese Aufgabe gelöst, indem das Reißen eines Stegteils am Umfang der durch senkrechte Projektion einer der Kavitäten auf den Leiterbahnträger definierte Fläche vermieden wird.According to the invention, this object is achieved by avoiding the tearing of a web part on the circumference of the surface defined by vertical projection of one of the cavities onto the conductor carrier.
Gemäß einem Aspekt der Erfindung wird die Lösung der Aufgabe mit einer Blisterpackungsanordnung gemäß Anspruch 1 umgesetzt. Das Reißen eines Stegteils am Umfang der durch senkrechte Projektion einer der Kavitäten auf den Leiterbahnträger definierte Fläche wird hier dadurch vermieden, dass das zu durchtrennende Stegteil in die durch senkrechte Projektion der Kavität auf den Leiterbahnträger definierte Fläche hinein verlegt wird. Gegenüber der herkömmlichen Ausführung eines Stegteils am Rand der durch senkrechte Projektion der Kavität auf den Leiterbahnträger definierten Fläche ergeben sich so günstigere Krafteinleitungsverhältnisse, welche das Stegteil leichter reißen lassen. Alternativ kann auch auf das Stegteil ganz verzichtet und ein innerhalb er durch senkrechte Projektion der Kavität auf den Leiterbahnträger definierten Fläche angeordneter Stanzlinienabschnitt direkt mit der Leiterbahn überdruckt werden.According to one aspect of the invention, the solution of the problem with a blister pack assembly according to
Gemäß einem weiteren Aspekt der Erfindung wird die Lösung der zugrundeliegenden Aufgabe mit einer Blisterpackungsanordnung gemäß Anspruch 19 umgesetzt. Das Reißen eines Stegteils am Umfang der durch senkrechte Projektion einer der Kavitäten auf den Leiterbahnträger definierte Fläche wird hier dadurch vermieden, dass zum Unterbrechen der Leiterbahn überhaupt kein Stegteil zu durchtrennen ist, sondern die Leiterbahn eine die Medikamentenentnahme erleichternde Stanzlinie kreuzt, ohne dass an der Kreuzungsstelle die Stanzlinie durch ein Stegteil unterbrochen wäre. Es muss also überhaupt kein Stegteil durchtrennt werden. Um dennoch einen für die Spendbarkeit erforderlichen Zusammenhalt zwischen der durch senkrechte Projektion der Kavität auf den Leiterbahnträger definierten Fläche und der Restfläche des Leiterbahnträgers zu erreichen, kann vorteilhafterweise eine sogenannte Spendeüberlappung (deren Grundprinzip in
Vorteilhafte Ausführungsformen der Erfindung können gemäß einem der Ansprüche 2-18 und 20-26 ausgestaltet sein. Stanzlinien können dabei grundsätzlich sowohl in Form einfacher Stanzlinien, als auch in Form spaltartiger Ausnehmungen vorgesehen sein.Advantageous embodiments of the invention may be configured according to any one of claims 2-18 and 20-26. Punching lines can basically be provided both in the form of simple punched lines, as well as in the form of gap-like recesses.
Grundsätzlich kann jede im Rahmen der vorliegenden Anmeldung beschriebene bzw. angedeutete Variante der Erfindung besonders vorteilhaft sein, je nach wirtschaftlichen und technischen Bedingungen im Einzelfall. Soweit nichts gegenteiliges dargelegt ist, bzw. soweit grundsätzlich technisch realisierbar, sind einzelne Merkmale der beschriebenen Ausführungsformen austauschbar oder miteinander sowie auch mit aus dem Stand der Technik per se bekannten Maßnahmen kombinierbar.In principle, any variant of the invention described or indicated in the context of the present application may be particularly advantageous, depending on the economic and technical conditions in the individual case. Unless otherwise stated, or as far as technically feasible, individual features of the described embodiments are interchangeable or can be combined with one another as well as with measures known per se from the prior art.
Nachfolgend werden anhand der zugehörigen Zeichnungen Beispiele bevorzugter Ausführungsformen der vorliegenden Erfindung näher erläutert. Die Zeichnungen sind dabei rein schematische und, aus Gründen der Anschaulichkeit, nicht maßstäbliche Darstellungen. Insbesondere können Verhältnisse der Abmessungen zueinander von tatsächlichen Ausführungen abweichen.Hereinafter, examples of preferred embodiments of the present invention will be explained in detail with reference to the accompanying drawings. The drawings are purely schematic and, for reasons of clarity, not to scale representations. In particular, ratios of dimensions to each other may differ from actual embodiments.
Einander entsprechende Elemente sind in den einzelnen Figuren jeweils, soweit sinnvoll, mit den gleichen Bezugszeichen versehen.
- Fig. 1
- zeigt den Leiterbahnträger einer erfindungsgemäßen Blisterpackungsanordnung in der Draufsicht, wobei exemplarisch zehn verschiedene Stanzbilder (1.1-1.10) zur Erleichterung der Medikamentenentnahme dargestellt sind.
- Fig. 2a-c
- zeigen in einer schematischen Querschnittsdarstellung drei verschiedene Anordnungsvarianten einer eine Stanzlinie direkt kreuzenden Leiterbahn bei erfindungsgemäßen Blisterpackungsanordnungen.
- Fig. 2d
- zeigt eine detailliertere Ansicht der Einzelheit E aus
Fig. 2c in der Vergrößerung. - Fig. 3
- zeigt den Leiterbahnträger einer gemäß
Fig. 2c-d ausgeführten Blisterpackungsanordnung in der Draufsicht. - Fig. 4
- zeigt den Leiterbahnträger einer ähnlich Variante 1.5 aus
Fig. 1 ausgeführten Blisterpackungsanordnung in der Draufsicht mit zwei verschiedenen Leiterbahnführungen, nämlich zum einen direkt eine Stanzlinie kreuzend, zum anderen über ein eine Stanzlinie unterbrechendes Stegteil. - Fig. 5
- zeigt den Leiterbahnträger einer Blisterpackungsanordnung gemäß einer weiteren Ausführungsform der vorliegenden Erfindung.
- Fig. 1
- shows the conductor carrier of a blister pack assembly according to the invention in plan view, with exemplary ten different punch images (1.1-1.10) are shown to facilitate the withdrawal of medication.
- Fig. 2a-c
- show in a schematic cross-sectional view three different arrangement variants of a punching line directly crossing conductor track in blister pack assemblies according to the invention.
- Fig. 2d
- shows a more detailed view of detail E.
Fig. 2c in the enlargement. - Fig. 3
- shows the conductor carrier according to
Fig. 2c-d executed blister pack assembly in plan view. - Fig. 4
- shows the conductor carrier of a similar variant 1.5
Fig. 1 executed blister pack assembly in plan view with two different conductor track guides, namely on the one hand directly crossing a punching line, on the other hand via a punch line interrupting web part. - Fig. 5
- shows the conductor carrier of a blister pack assembly according to another embodiment of the present invention.
In
Mit ovalen Linien angedeutet sind die durch senkrechte Projektion der (Tabletten, Pillen oder Dragees enthaltenden) Kavitäten 7 auf den Leiterbahnträger definierten Flächen angedeutet Der Leiterbahnträger ist aus einem Flachmaterial 4 hergestellt, bei welchem es sich beispielsweise um eine Kunststofffolie (PET, PE, PP, PVC, PA ...), einen Folienverbund oder Papier handeln kann. Die Leiterbahnen 1 sind auf das Flachmaterial 4 aufgedruckt. Jeder Kavität 7 ist dabei eine eigene Leiterschleife zugeordnet. Ob diese durchgängig ist, kann über die in
In allen zehn in
Die Verzweigung der Stanzlinien 3 erleichtert zudem insgesamt das Aufreißen des Flachmaterials 4 im Bereich der zugehörigen Kavität 7, wenn die/das in der Kavität 7 angeordnete Tablette, Pille oder Dragee durch Druck auf die Kavität 7 aus dieser herausgedrückt wird.The branching of the
Besonders begünstigt ist die Krafteinleitung dadurch, dass das Stegteil 2 eine Stanzlinie 3 unterbricht, welche die durch senkrechte Projektion der zugehörigen Kavität 7 auf den Leiterbahnträger definierte Fläche etwa in zwei (in der Darstellung obere und untere) Hälften teilt.The introduction of force is particularly favored by the fact that the
Dabei können die Stanzlinien 3 vollständig innerhalb der durch senkrechte Projektion der zugehörigen Kavität 7 auf den Leiterbahnträger definierten Fläche liegen (Varianten 1.1 bis 1.9), ober auch über diese hinausreichen (Variante 1.10).In this case, the punched
Die in
Um trotz der umlaufenden Stanzlinien 3 eine Verbindung zwischen der durch senkrechte Projektion der zugehörigen Kavität 7 auf den Leiterbahnträger definierten Fläche und der Restfläche des Leiterbahnträgers zu erhalten, sind zwei Folienlagen 4a, 4b mit zueinander versetzten Stanzlinien 3a, 3b vorgesehen. Dabei kann der in
Ferner kann die Kraft, mit der die durch senkrechte Projektion der zugehörigen Kavität 7 auf den Leiterbahnträger definierte Fläche an der Restfläche des Leiterbahnträgers haftet durch entsprechende Wahl des Abstands zwischen den versetzten Stanzlinien 3a, 3b eingestellt werden.Furthermore, the force with which the surface defined by vertical projection of the associated
Anstelle einer Verklebung kann auch eine andere Verbindung zwischen den Lagen 4a und 4b vorgesehen sein, beispielsweise mittels einer Siegelschicht, eines Haftvermittlers, Schweißstellen etc.Instead of a bond, another connection between the
Wie aus der Einzelheit E in
Die Leiterbahn 1 kann, wie in
Grundsätzlich können beim direkten Überdrucken von Stanzlinien mit einer Leiterbahn 1 Probleme entstehen. Zum einen kann es beim Verspenden zu einer unerwünschten Trennung der Leiterbahn kommen, zum ändern können aufgrund von Höhenunterschieden an der Stanzkante lokale Verdünnungen des Leiterbahnquerschnitts auftreten, welche den elektrischen Widerstand über Gebühr erhöhen. Als vorteilhafte Gegenmaßnahme bietet sich, neben der im Zusammenhang mit
Weiter ist es unter dem Gesichtspunkt der Stanzkantenüberdruckung günstig, die Folienlage 4, 4a, 4b, auf welche die Leiterbahn 1 gedruckt wird, möglichst dünn auszuführen, ein elastisches Leiterbahnmaterial zu verwenden und/oder die Leiterbahn mit einem Lack oder einer verdruckbaren Masse zu unterlegen.Further, from the viewpoint of punching edge overprinting, it is favorable to make the
Claims (26)
der Leiterbahnträger zumindest im Bereich der Kreuzung von Leiterbahn (1) und gekreuztem Stanzlinienabschnitt (3a) mindestens zweilagig ausgeführt ist,
der gekreuzte Stanzlinienabschnitt (3a) in einer Lage (4a) des Leiterbahnträgers ausgeführt ist und sich mit einem ungestanzten Flächenbereich einer weiteren Lage (4b) des Leiterbahnträgers überdeckt, und
die weitere Lage (4b) des Leiterbahnträgers eine zum gekreuzten Stanzlinienabschnitt (3a) versetzten Stanzlinienabschnitt (3b) aufweist.A blister pack assembly according to any one of claims 7-8, wherein
at least in the region of the intersection of the conductor track (1) and the crossed punching line section (3a) the conductor track carrier is designed to be at least two-ply,
the crossed punch line section (3a) is embodied in one layer (4a) of the conductor carrier and overlaps with an unpunched surface region of another layer (4b) of the conductor carrier, and
the further layer (4b) of the conductor carrier has a punched line section (3b) offset from the crossed punch line section (3a).
der Leiterbahnträger zumindest im Bereich der Kreuzung von Leiterbahn (1) und gekreuzter Stanzlinie (3) mindestens zweilagig ausgeführt ist,
die gekreuzte Stanzlinie (3a) in einer Lage (4a) des Leiterbahnträgers ausgeführt ist und sich mit einem ungestanzten Flächenbereich einer weiteren Lage (4b) des Leiterbahnträgers überdeckt, und
die weitere Lage (4b) des Leiterbahnträgers eine zur gekreuzten Stanzlinie (3a) versetzte Stanzlinie (3b) aufweist.A blister pack assembly according to claim 19, wherein
at least in the region of the intersection of conductor track (1) and crossed punch line (3) the conductor track carrier is designed to be at least two-ply,
the crossed punching line (3a) is embodied in one layer (4a) of the conductor carrier and overlaps with an unpunched surface region of another layer (4b) of the conductor carrier, and
the further layer (4b) of the conductor carrier has a punched line (3b) offset from the crossed line (3a).
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08100536A EP2080502B1 (en) | 2008-01-16 | 2008-01-16 | Blister pack assembly |
AT08100536T ATE534365T1 (en) | 2008-01-16 | 2008-01-16 | BLISTER PACK ARRANGEMENT |
EP09701699.2A EP2242469B1 (en) | 2008-01-16 | 2009-01-14 | Blister pack assembly |
PCT/EP2009/000177 WO2009090048A1 (en) | 2008-01-16 | 2009-01-14 | Blister pack arrangement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08100536A EP2080502B1 (en) | 2008-01-16 | 2008-01-16 | Blister pack assembly |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2080502A1 true EP2080502A1 (en) | 2009-07-22 |
EP2080502B1 EP2080502B1 (en) | 2011-11-23 |
Family
ID=39467197
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08100536A Active EP2080502B1 (en) | 2008-01-16 | 2008-01-16 | Blister pack assembly |
EP09701699.2A Active EP2242469B1 (en) | 2008-01-16 | 2009-01-14 | Blister pack assembly |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09701699.2A Active EP2242469B1 (en) | 2008-01-16 | 2009-01-14 | Blister pack assembly |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP2080502B1 (en) |
AT (1) | ATE534365T1 (en) |
WO (1) | WO2009090048A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2484660A (en) * | 2010-10-14 | 2012-04-25 | Future Technology Uk Ltd | Electrically Monitored Seal for a Blister Pack |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011018199A1 (en) * | 2011-04-19 | 2012-10-25 | Schreiner Group Gmbh & Co. Kg | Detection element for recognizing removal of e.g. sugar coated pill from blister packaging unit, has electrical conductive strip conductor arrangement having strip conductors that are intersected with weakening lines of detection film |
CN103413206B (en) * | 2013-08-28 | 2016-06-29 | 上海爱信诺航芯电子科技有限公司 | A kind of intelligent RFID medicine plate system suitable in medicine board management |
US10930383B2 (en) | 2015-07-03 | 2021-02-23 | Cuepath Innovation Inc. | Connected sensor substrate for blister packs |
CA2991253C (en) * | 2015-07-03 | 2022-05-10 | Cuepath Innovation Inc. | Connected sensor substrate for blister packs |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5412372A (en) * | 1992-09-21 | 1995-05-02 | Medical Microsystems, Inc. | Article dispenser for monitoring dispensing times |
EP1507248A1 (en) | 2003-08-14 | 2005-02-16 | Schreiner Group GmbH & Co. KG | Hanger label |
DE102004060213A1 (en) | 2003-12-19 | 2005-07-28 | Udo Simon | Blister packing arrangement for tablets has conductor strip carrier with openings formed by stamped lines encompassing respective regions corresponding to pockets in blister packing and broken by two bridge sections |
US6973371B1 (en) * | 2004-10-13 | 2005-12-06 | Nadir Benouali | Unit dose compliance monitoring and reporting device and system |
WO2007138520A1 (en) * | 2006-05-30 | 2007-12-06 | Nxp B.V. | Electronic blister pack |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0120018D0 (en) * | 2001-08-16 | 2001-10-10 | Meridica Ltd | Pack containing medicament and dispensing device |
CN102036881B (en) * | 2008-05-22 | 2012-06-20 | Wm.雷格利Jr.公司 | Dual laser scored blister package cover |
-
2008
- 2008-01-16 AT AT08100536T patent/ATE534365T1/en active
- 2008-01-16 EP EP08100536A patent/EP2080502B1/en active Active
-
2009
- 2009-01-14 WO PCT/EP2009/000177 patent/WO2009090048A1/en active Application Filing
- 2009-01-14 EP EP09701699.2A patent/EP2242469B1/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5412372A (en) * | 1992-09-21 | 1995-05-02 | Medical Microsystems, Inc. | Article dispenser for monitoring dispensing times |
EP1507248A1 (en) | 2003-08-14 | 2005-02-16 | Schreiner Group GmbH & Co. KG | Hanger label |
DE102004060213A1 (en) | 2003-12-19 | 2005-07-28 | Udo Simon | Blister packing arrangement for tablets has conductor strip carrier with openings formed by stamped lines encompassing respective regions corresponding to pockets in blister packing and broken by two bridge sections |
US6973371B1 (en) * | 2004-10-13 | 2005-12-06 | Nadir Benouali | Unit dose compliance monitoring and reporting device and system |
WO2007138520A1 (en) * | 2006-05-30 | 2007-12-06 | Nxp B.V. | Electronic blister pack |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2484660A (en) * | 2010-10-14 | 2012-04-25 | Future Technology Uk Ltd | Electrically Monitored Seal for a Blister Pack |
GB2484660B (en) * | 2010-10-14 | 2012-10-10 | Future Technology Uk Ltd | Seals |
CN103415448A (en) * | 2010-10-14 | 2013-11-27 | 未来技术(英国)有限公司 | Seals |
US8973773B2 (en) | 2010-10-14 | 2015-03-10 | Future Technology (Uk) Ltd | Seals |
CN103415448B (en) * | 2010-10-14 | 2015-07-15 | 未来技术(英国)有限公司 | Contrainer for storing and distributing consumption products and seals used together with same |
Also Published As
Publication number | Publication date |
---|---|
EP2242469B1 (en) | 2016-05-04 |
EP2242469A1 (en) | 2010-10-27 |
ATE534365T1 (en) | 2011-12-15 |
EP2080502B1 (en) | 2011-11-23 |
WO2009090048A1 (en) | 2009-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69835292T2 (en) | DEVICE FOR DETECTING A MEDICAMENT DELIVERY | |
DE10213547C1 (en) | Blister pack, for tablets/capsules, has a carrier plate for the pack with a covering layer incorporating the conductor paths to the separate pockets to register the removal from a pocket | |
EP2059455B1 (en) | Packaging for films which contain active substances, and method for producing it | |
EP2242469B1 (en) | Blister pack assembly | |
DE60310144T2 (en) | SUPPLY VESSEL | |
WO2005058723A1 (en) | Blister packing device | |
EP1770024A2 (en) | Packaging | |
EP0943138B1 (en) | Flat transdermal medicated self-adhesive patch | |
DE10102818A1 (en) | Primary packaging unit for several isolated film platelets as dosage forms | |
DE3317549A1 (en) | Device for removing capsules, tablets or sugar-coated tablets from blister packs | |
EP1474090B1 (en) | Device for detecting the removal of a product from a packing system by an electronic unit | |
DE3530356C2 (en) | ||
EP0139855A1 (en) | Device for intra-anal application of medicaments in liquid or pasty form | |
EP1394600B1 (en) | Multilayer label | |
WO1996034808A1 (en) | Process for producing products secured to a substrate, like packed samples, credit and identity cards ant the like | |
DE102012104460A1 (en) | Oversize label for transferring the circumference of an object | |
EP2475592B1 (en) | Security label for securing medications retained in an individual packaging | |
DE19957809B4 (en) | Use of a blister pack | |
DE10008165A1 (en) | Packaging of sheet-like objects with improved tear properties | |
WO2017158149A1 (en) | Single-dose applicator and method for producing same | |
EP1985550A1 (en) | Packaging unit for medicines and method for its manufacture | |
EP3166565B1 (en) | Detection unit for detecting the removal of medicines | |
WO2022268470A1 (en) | Labelling arrangement and method for producing a labelling arrangement for a syringe, and syringe system | |
EP4119120A1 (en) | Packaging with a time display device | |
WO2017067691A1 (en) | Outer packaging for blister packaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
17P | Request for examination filed |
Effective date: 20091211 |
|
17Q | First examination report despatched |
Effective date: 20100118 |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: FREI PATENTANWALTSBUERO AG |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502008005645 Country of ref document: DE Effective date: 20120216 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120323 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120223 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120323 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120224 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120223 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120131 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20120824 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502008005645 Country of ref document: DE Effective date: 20120824 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120305 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080116 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: NEW ADDRESS: POSTFACH, 8032 ZUERICH (CH) |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20200121 Year of fee payment: 13 Ref country code: IE Payment date: 20200122 Year of fee payment: 13 Ref country code: NL Payment date: 20200122 Year of fee payment: 13 Ref country code: IT Payment date: 20200122 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20200127 Year of fee payment: 13 Ref country code: BE Payment date: 20200122 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20210201 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 534365 Country of ref document: AT Kind code of ref document: T Effective date: 20210116 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210116 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210131 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210131 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230123 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230124 Year of fee payment: 16 Ref country code: DE Payment date: 20230119 Year of fee payment: 16 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230515 |